-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Cannabis Bioscience International Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from Q4 2022 to Q3 2024.
- Cannabis Bioscience International Holdings, Inc. Cost of Revenue for the quarter ending August 31, 2024 was $8.36K, a 5.19% decline year-over-year.
- Cannabis Bioscience International Holdings, Inc. Cost of Revenue for the twelve months ending August 31, 2024 was $45.1K.
- Cannabis Bioscience International Holdings, Inc. annual Cost of Revenue for 2023 was $45.6K, a 51.2% decline from 2022.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)